Norcomed
Latest round
- Series A
Last raised
- May 2018
Total raised
- Undisclosed
Investors
- 3
About Norcomed
Established in 2013 and based in Beijing, China, Norcomed operates as a biotechnology company that focuses on the production of consumables for minimally invasive orthopedic spine surgery. The core research team comes from PLA General Hospital and Tsinghua University. The company provides orthopedic medical devices and minimally invasive spine surgery solutions. Its products include spinal surgery access system and disposable laparotomy tube. The company is developing 3D-printed products for orthopedic endosseous plants.
Who invested in Norcomed
3 investors across 1 round
See all investors in Norcomed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
May 21, 2018
Amount
Undisclosed
Investors
Questions about Norcomed
Who invested in Norcomed?
Norcomed has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Norcomed raised?
Norcomed has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Norcomed last raise money?
Norcomed's most recent round on record is a Series A, in May 2018.
What does Norcomed do?
Established in 2013 and based in Beijing, China, Norcomed operates as a biotechnology company that focuses on the production of consumables for minimally invasive orthopedic spine surgery.
Where is Norcomed headquartered?
Norcomed is headquartered in Beijing, China.
Which VCs invest in companies like Norcomed?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back medical devices & equipment companies at Norcomed's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series A
Raising like Norcomed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.